Piercarlo Meinero1,2, Marco La Torre1,3, Giorgio Lisi4,5, Alessandro Stazi6, Antonella Carbone1,7, Luca Regusci2, Fabrizio Fasolini2. 1. Colorectal Unit Sanatrix Clinic, Rome, Italy. 2. Department of Surgery, EOC Hospital, Mendrisio, Switzerland. 3. General Surgery and Proctology, University Pittsburgh Medical Center - Salvator Mundi International Hospital, Rome, Italy. 4. Department of Surgery, Sant'Eugenio Hospital, Rome, Italy. giolimas06@yahoo.it. 5. Department of General Surgery, Sant'Eugenio Hospital, Rome, Italy. giolimas06@yahoo.it. 6. Pelvic Care Center, Madonna delle Grazie Hospital, Velletri, Rome, Italy. 7. Policlinico Umberto I Hospital, Sapienza University of Rome, Rome, Italy.
Abstract
BACKGROUND: Pilonidal disease (PD) is a common disease of the natal cleft, which can lead to complications including infection and abscess formation. Various operative management options are available, but the ideal technique is still debatable. Recurrent PD after surgical treatment is frequent event for the 25-30% of cases. The present study evaluated endoscopic pilonidal sinus treatment (EPSiT) in recurrent and multi-recurrent PD. METHODS: Of the consecutive prospective patients with recurrent PD, 122 were enrolled in a prospective international multicenter study conducted at a secondary and tertiary colorectal surgery centers. Primary endpoint was to evaluate short- and long-term outcomes: healing rate/time, morbidity rate, re-recurrence rate, and patient's quality of life (QoL). RESULTS: Complete wound healing rate was occurred in 95% of the patient, with a mean complete wound healing time of 29 ± 12 days. The incomplete healing rate (5%) was significantly related to the number of external openings (p = 0.008), and recurrence was reported in six cases (5.1%). Normal daily activity was established on the first postoperative day, and the mean duration before patients returned to work was 3 days. QoL significantly increased between the preoperative stage and 30 days after the EPSiT procedure (45.3 vs. 7.9; p < 0.0001). CONCLUSIONS: The EPSiT procedure seems to be a safe and effective technique in treating even complex recurrent PD. It enables excellent short- and long-term outcomes than various other techniques that are more invasive.
BACKGROUND:Pilonidal disease (PD) is a common disease of the natal cleft, which can lead to complications including infection and abscess formation. Various operative management options are available, but the ideal technique is still debatable. Recurrent PD after surgical treatment is frequent event for the 25-30% of cases. The present study evaluated endoscopic pilonidal sinus treatment (EPSiT) in recurrent and multi-recurrent PD. METHODS: Of the consecutive prospective patients with recurrent PD, 122 were enrolled in a prospective international multicenter study conducted at a secondary and tertiary colorectal surgery centers. Primary endpoint was to evaluate short- and long-term outcomes: healing rate/time, morbidity rate, re-recurrence rate, and patient's quality of life (QoL). RESULTS: Complete wound healing rate was occurred in 95% of the patient, with a mean complete wound healing time of 29 ± 12 days. The incomplete healing rate (5%) was significantly related to the number of external openings (p = 0.008), and recurrence was reported in six cases (5.1%). Normal daily activity was established on the first postoperative day, and the mean duration before patients returned to work was 3 days. QoL significantly increased between the preoperative stage and 30 days after the EPSiT procedure (45.3 vs. 7.9; p < 0.0001). CONCLUSIONS: The EPSiT procedure seems to be a safe and effective technique in treating even complex recurrent PD. It enables excellent short- and long-term outcomes than various other techniques that are more invasive.
Authors: Asd Liyanage; Y Woods; M A Javed; C Deftly; H Shaban; R Kalaiselvan; R Rajaganeshan Journal: Ann R Coll Surg Engl Date: 2020-04-17 Impact factor: 1.891
Authors: Nunzio Velotti; Michele Manigrasso; Katia Di Lauro; Enrico Araimo; Federica Calculli; Sara Vertaldi; Pietro Anoldo; Giovanni Aprea; Giuseppe De Simone; Antonio Vitiello; Mario Musella; Marco Milone; Giovanni Domenico De Palma; Francesco Milone; Loredana Maria Sosa Fernandez Journal: Open Med (Wars) Date: 2019-08-07
Authors: Sara Vertaldi; Pietro Anoldo; Grazia Cantore; Alessia Chini; Anna D'Amore; Maria D'Armiento; Nicola Gennarelli; Francesco Maione; Michele Manigrasso; Alessandra Marello; Pietro Schettino; Carmen Sorrentino; Loredana M Sosa Fernandez; Giovanni D De Palma; Marco Milone Journal: Front Surg Date: 2022-03-03
Authors: Michele Manigrasso; Pietro Anoldo; Grazia Cantore; Alessia Chini; Anna D'Amore; Nicola Gennarelli; Francesco Maione; Alessandra Marello; Pietro Schettino; Carmen Sorrentino; Sara Vertaldi; Loredana Maria Sosa Fernandez; Giovanni Domenico De Palma; Marco Milone Journal: Front Surg Date: 2022-01-04
Authors: R Perinotti; G Gallo; M Milone; L Basso; M Manigrasso; R Pietroletti; A Bondurri; M La Torre; G Milito; M Pozzo; D Segre Journal: Tech Coloproctol Date: 2021-06-27 Impact factor: 3.781